Indian Immunologicals Ltd (IIL) is a leading biological company in the country. On Monday, November 2, 2015, IIL inaugurated its new bovine serum manufacturing facility in New Zealand.
A statement by IIL said, "Pristine Biologicals (NZ) Ltd (PBL), a wholly owned subsidiary of IIL, was inaugurated by National Dairy Development Board (NDDB) chairman T. Nanda Kumar, in the presence of New Zealander's Food Safety Development and Primary Industries Minister Jo Goodhew, IIL MD and PBL director K. V. Balasubramaniam."
‘IIL has inaugurated a new bovine serum manufacturing facility in New Zealand. With this new facility IIL not only becomes self sufficient for a key ingredient, but will also have spare capacity to provide it to other quality conscious manufacturers.’
IIL established PBL in 2014 to gain control over the supplies of a key ingredient used in vaccine manufacture. Serum from New Zealand is highly regarded as the country is free from several diseases listed by the World Organization for Animal Health (OIE). This new plant can manufacture up to 300 tonne of serum.
Balasubramaniam said, "Pristine would bring the science of biopharmaceuticals to the users of bovine serum and the rigor in quality assurance and management which will in turn ensure that users bring high quality to their products."
IIL's deputy managing director Anand Kumar said, "With this new facility IIL not only becomes self sufficient for a key ingredient but also has spare capacity to provide it to other quality conscious manufacturers as well."